Life Science Investing Coherus Management to Present at the 44th Annual J.P. Morgan Healthcare Conference
Life Science Investing Coherus Oncology Announces Publication in Molecular Cancer Therapeutics Highlighting the Strong Pharmacology of Investigational CCR8 Antibody Tagmokitug
Life Science Investing Coherus Announces Six-Year JUPITER-02 Follow-up Results Showing LOQTORZI® plus Chemotherapy Nearly Doubles Median Overall Survival in Nasopharyngeal Carcinoma
Life Science Investing Coherus Oncology Presents at SITC Clinical Multiomic Biomarker Data for CHS-114, a Highly Selective anti-CCR8 Cytolytic Antibody
Life Science Investing Coherus Oncology Reports Third Quarter 2025 Financial Results and Provides Business Update
Life Science Investing Arvind Sood joins Coherus Oncology as Chief Strategy and Corporate Affairs Officer
Life Science Investing Coherus Oncology to Report Third Quarter 2025 Financial Results on November 6, 2025
Life Science Investing Coherus Oncology Announces Poster Presentation at the 40th Annual Meeting of the Society for Immunotherapy of Cancer
Locksley Confirms Continuous High Grade Mineralized Silver Corridor at its Mojave Project in California
Homerun Resources Inc. Closes Acquisition of Additional Mineral Rights in the Santa Maria Eterna Silica Sand District
Rio Silver Highlights High-Grade Silver up to 6.26 g/t Au and 991 g/t Ag over 0.70 metres at Maria Norte and Advances a Clear Near-Term Development Path in Peru
NevGold Identifies Large Quantities of Previously Mined Material With Significant Antimony And Near-Term Production Potential In Historical Leach Pads at Limo Butte, Nevada
